These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 5119348

  • 1. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
    Geissbuhler F, Bartholini G, Gaillard JM, Tissot R.
    Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
    [No Abstract] [Full Text] [Related]

  • 2. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
    Geissbuhler F, Eisenring JJ, Friedli P, Bartholini G, Tissot R.
    Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
    Stammler A, Vielhaber K.
    Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
    [No Abstract] [Full Text] [Related]

  • 4. [Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
    Eisenring JJ, Dick P, Tissot R, Yanniotis G.
    Psychopharmacologia; 1973 Oct 23; 33(1):95-101. PubMed ID: 4769026
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Matussek N, Benkert O, Schneider K, Otten H, Pohlmeier H.
    Arzneimittelforschung; 1970 Jul 23; 20(7):934-5. PubMed ID: 4918921
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

  • 14. [Familial syndrome with parkinsonian tremor and anosmia and its therapy with L-dopa associated with a decarboxylase inhibitor].
    Constantinidis J, de Ajuriaguerra J.
    Therapeutique; 1970 Mar 23; 46(3):263-9. PubMed ID: 5422192
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR, Messiha FS, Hsu TH.
    Clin Pharmacol Ther; 1972 Mar 23; 13(4):584-94. PubMed ID: 5042372
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
    Steinhäusl H.
    Wien Med Wochenschr; 1973 Jun 30; 123(26):433-5. PubMed ID: 4578743
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A.
    Brux Med; 1972 Oct 30; 52(10):673-80. PubMed ID: 4656191
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
    Streifler M, Vardi J, Kesten M.
    Harefuah; 1972 Nov 01; 83(9):362-4. PubMed ID: 4669737
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of a decarboxylase inhibitor (Ro 4-4602) and L-dopa on inhibited depressions. II. Experimental psychological studies].
    Pohlmeier H, Schön I, Matussek N.
    Arzneimittelforschung; 1970 Jul 01; 20(7):932-3. PubMed ID: 4918920
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.